Cargando…
Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
Agomelatine, a melatonergic antidepressant with a rapid onset of action, is one of the most recent drugs in the antidepressant category. Agomelatine’s antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmati...
Autores principales: | De Berardis, Domenico, Fornaro, Michele, Serroni, Nicola, Campanella, Daniela, Rapini, Gabriella, Olivieri, Luigi, Srinivasan, Venkataramanujam, Iasevoli, Felice, Tomasetti, Carmine, De Bartolomeis, Andrea, Valchera, Alessandro, Perna, Giampaolo, Mazza, Monica, Di Nicola, Marco, Martinotti, Giovanni, Di Giannantonio, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307293/ https://www.ncbi.nlm.nih.gov/pubmed/25569089 http://dx.doi.org/10.3390/ijms16011111 |
Ejemplares similares
-
The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2013) -
Successful Ziprasidone Monotherapy in a Case of Delusional Parasitosis: A One-Year Followup
por: De Berardis, Domenico, et al.
Publicado: (2013) -
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review
por: de Berardis, Domenico, et al.
Publicado: (2017) -
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
por: De Berardis, Domenico, et al.
Publicado: (2020) -
S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study
por: De Berardis, Domenico, et al.
Publicado: (2013)